Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Goodrx Holdings Inc Cl A (NQ: GDRX ) 6.190 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Goodrx Holdings Inc Cl A < Previous 1 2 3 4 5 6 7 8 9 Next > GoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) August 16, 2024 Via Benzinga GoodRx (GDRX) Q2 2024 Earnings Call Transcript August 08, 2024 GDRX earnings call for the period ending June 30, 2024. Via The Motley Fool Topics Earnings Exposures Financial GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges August 08, 2024 GoodRx reported Q2 revenue of $200.61M, a 6% YoY increase. Prescription transactions revenue rose 7%, driven by 8% growth in Monthly Active Consumers. The company expects FY 2024 revenue at the lower... Via Benzinga MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday July 15, 2024 Via Benzinga 3 Lawsuit-Laden Stocks to Dump Before Problems Multiply July 10, 2024 These stocks to sell face ongoing and past litigation, but that isn't the only sticking point in their long-term prospects. Via InvestorPlace The Analyst Landscape: 7 Takes On GoodRx Holdings June 10, 2024 Via Benzinga Forecasting The Future: 13 Analyst Projections For GoodRx Holdings May 16, 2024 Via Benzinga Why GoodRx Surged Today March 25, 2024 The prescription-drug upstart got an upgrade from Wall Street. Via The Motley Fool Market Correction Alert: Sell These 3 Tech Stocks While You Can June 28, 2024 These tech stocks to sell combine shaky operational outlooks with underlying fundamental shakiness that don't bode well for the long-term. Via InvestorPlace 3 Stocks to Sell ASAP Before the June 27 Presidential Debate June 17, 2024 These stocks to sell sit within politically sensitive sectors, making them too risky to hold as we approach election season. Via InvestorPlace The 3 Most Undervalued Under-$10 Stocks to Buy in June 2024 June 04, 2024 These three, sub $10 stocks with enormous upside potential might just be your best investment nuggets this month. Via InvestorPlace GoodRx Strengthens Core Business With New Initiatives, Analyst Upgrades On Potential Opportunities May 23, 2024 GoodRx has been upgraded by RBC Capital Markets due to the growth potential from the Integrated Savings Program, direct contracting initiatives, and manufacturing solutions expansion. Via Benzinga GoodRx Shares Soar Nearly 10% As New Partnership With Kroger Promises Big Savings May 15, 2024 GoodRX shares surged nearly 10% Wednesday afternoon following the announcement of a new direct contracting agreement with Kroger Co. (NYSE:KR). Via Benzinga The Latest Analyst Ratings For GoodRx Holdings March 25, 2024 Via Benzinga Earnings Scheduled For February 29, 2024 February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. Via Benzinga In-Depth Examination Of 4 Analyst Recommendations For GoodRx Holdings February 26, 2024 Via Benzinga NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday May 15, 2024 Via Benzinga GoodRx (GDRX) Q1 2024 Earnings Call Transcript May 09, 2024 GDRX earnings call for the period ending March 31, 2024. Via The Motley Fool Topics Earnings Exposures Financial Change Healthcare Cyberattack: GoodRx Expects Low Single Digit Million-Dollar Impact In 2024 May 09, 2024 GoodRx's Q1 earnings: $0.08 EPS, sales hit $197.88 million, beating expectations fueled by prescription transactions and pharma solutions. Q2 forecast: ~$200 million revenue, optimistic 2024 outlook. Via Benzinga GDRX Stock Earnings: GoodRx Holdings Beats EPS, Beats Revenue for Q1 2024 May 09, 2024 GDRX stock results show that GoodRx Holdings beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings April 10, 2024 GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst. Via Benzinga Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 25, 2024 Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. Via Benzinga Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says March 25, 2024 Wells Fargo's upgrade of GoodRx Holdings. Analysts anticipate strong revenue visibility and EBITDA margins, setting the stage for potential stock outperformance in 2024-2025. Via Benzinga Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session March 25, 2024 U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading. Via Benzinga Topics Stocks Exposures US Equities These Analysts Increase Their Forecasts On GoodRx Following Q4 Earnings March 01, 2024 GoodRx Holdings, Inc. (NASDAQ: GDRX) reported upbeat fourth-quarter FY23 results and issued first-quarter revenue guidance above estimates. Via Benzinga Why GoodRx Stock Soared Today February 29, 2024 The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance. Via The Motley Fool GoodRx (GDRX) Q4 2023 Earnings Call Transcript February 29, 2024 GDRX earnings call for the period ending December 31, 2023. Via The Motley Fool Topics Earnings Exposures Financial Why Is Telemedicine Firm GoodRx's Shares Surging Today February 29, 2024 GoodRx Holdings reported strong Q4 results and issued above-estimate revenue guidance for FY24. Revenue and adjusted EBITDA increased, company also announced new stock repurchase program. Via Benzinga Prescription Drug Discount Provider GoodRx Expects To Build Momentum In 2024, Stock Soars January 10, 2024 GoodRx Holdings Inc (NASDAQ: GDRX) provided preliminary Q4 FY23 revenue of $195 million-$197 million, up 6%-7% Y/Y, versus the consensus of $190.77 million. Via Benzinga Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 10, 2024 Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
